FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1805997582> ?p ?o ?g. }

• W1805997582 endingPage "107" @default.
• W1805997582 startingPage "100" @default.
• W1805997582 abstract "Despite widespread acknowledgement of cyathostomin resistance to adult icidal dosages of benzimidazole (BZD) anthelmintics, many strongyle control programs continue to feature regularly scheduled larvicidal treatment with fenbendazole (FBZ). However, no studies have been conducted to evaluate the efficacy of larvicidal regimens against encysted cyathostomins in a BZD-resistant (BZD-R) population. A masked, randomized, controlled clinical study was conducted with 18 juvenile horses harboring populations of cyathostomins that were considered BZD-R on the basis of fecal egg count reduction (FECR). Horses were blocked by prior history, ranked by egg counts, and allocated randomly to one of three treatment groups: 1—control, 2—FBZ >10 mg/kg once daily for five consecutive days, or 3—moxidectin (MOX) >0.4 mg/kg once. Fecal samples were collected prior to treatment and seven and 14 days after the final dose of anthelmintic. On Days 18–20, complete replicates of horses were euthanatized and necropsied, and 1% aliquots of large intestinal contents were recovered for determination of complete worm counts. The cecum and ventral colon were weighed, and measured proportions of the respective organ walls were processed for quantitation and characterization of encysted cyathostomin populations. The five-day regimen of FBZ achieved 44.6% fecal egg count reduction, had 56.4% activity against luminal adults and larvae, and was 38.6% and 71.2% effective against encysted early third stage (EL3) and late third stage/ fourth stage (LL3/L4) cyathostomin larvae, respectively. In contrast, MOX provided 99.9% FECR, removed 99.8% of luminal stages, and exhibited 63.6% and 85.2% efficacy against EL3 and LL3/L4 mucosal cyathostomins, respectively. Although BZD-R was the most feasible explanation for the lower larvicidal efficacies of FBZ, mean larval counts of moxidectin-treated horses were not significantly different from controls or those treated with FBZ. The lack of significant differences between larvicidal treatments was partially attributed to a small sample size and high variability among worm burdens. Historical differences in the time intervals between treatment and necropsy were identified as a confounding factor for accurate estimation of larvicidal efficacy. Determining appropriate post-treatment intervals for measuring larvicidal efficacy remains a critical regulatory and scientific challenge for this therapeutic area." @default.
• W1805997582 created "2016-06-24" @default.
• W1805997582 creator A5080276424 @default.
• W1805997582 creator A5083708742 @default.
• W1805997582 creator A5086301944 @default.
• W1805997582 date "2015-11-01" @default.
• W1805997582 modified "2023-10-16" @default.
• W1805997582 title "Comparison of the larvicidal efficacies of moxidectin or a five-day regimen of fenbendazole in horses harboring cyathostomin populations resistant to the adulticidal dosage of fenbendazole" @default.
• W1805997582 cites W1964105120 @default.
• W1805997582 cites W1972001186 @default.
• W1805997582 cites W1973003433 @default.
• W1805997582 cites W1973070469 @default.
• W1805997582 cites W1983356525 @default.
• W1805997582 cites W1984674626 @default.
• W1805997582 cites W1989570117 @default.
• W1805997582 cites W1992257126 @default.
• W1805997582 cites W1992793770 @default.
• W1805997582 cites W1992894760 @default.
• W1805997582 cites W2013289108 @default.
• W1805997582 cites W2036773531 @default.
• W1805997582 cites W2039711528 @default.
• W1805997582 cites W2040858278 @default.
• W1805997582 cites W2044555289 @default.
• W1805997582 cites W2044560862 @default.
• W1805997582 cites W2049914659 @default.
• W1805997582 cites W2051155963 @default.
• W1805997582 cites W2051936153 @default.
• W1805997582 cites W2056882773 @default.
• W1805997582 cites W2063166402 @default.
• W1805997582 cites W2074436440 @default.
• W1805997582 cites W2074863281 @default.
• W1805997582 cites W2079404940 @default.
• W1805997582 cites W2105136030 @default.
• W1805997582 cites W2155187485 @default.
• W1805997582 cites W2157246500 @default.
• W1805997582 cites W2170634083 @default.
• W1805997582 cites W2405524070 @default.
• W1805997582 doi "https://doi.org/10.1016/j.vetpar.2015.10.003" @default.
• W1805997582 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26477278" @default.
• W1805997582 hasPublicationYear "2015" @default.
• W1805997582 type Work @default.
• W1805997582 sameAs 1805997582 @default.
• W1805997582 citedByCount "29" @default.
• W1805997582 countsByYear W18059975822016 @default.
• W1805997582 countsByYear W18059975822017 @default.
• W1805997582 countsByYear W18059975822018 @default.
• W1805997582 countsByYear W18059975822019 @default.
• W1805997582 countsByYear W18059975822020 @default.
• W1805997582 countsByYear W18059975822021 @default.
• W1805997582 countsByYear W18059975822022 @default.
• W1805997582 countsByYear W18059975822023 @default.
• W1805997582 crossrefType "journal-article" @default.
• W1805997582 hasAuthorship W1805997582A5080276424 @default.
• W1805997582 hasAuthorship W1805997582A5083708742 @default.
• W1805997582 hasAuthorship W1805997582A5086301944 @default.
• W1805997582 hasConcept C126322002 @default.
• W1805997582 hasConcept C162156334 @default.
• W1805997582 hasConcept C2776026265 @default.
• W1805997582 hasConcept C2776186584 @default.
• W1805997582 hasConcept C2776908094 @default.
• W1805997582 hasConcept C2777499811 @default.
• W1805997582 hasConcept C2781348000 @default.
• W1805997582 hasConcept C2781413609 @default.
• W1805997582 hasConcept C2908647359 @default.
• W1805997582 hasConcept C42972112 @default.
• W1805997582 hasConcept C61716771 @default.
• W1805997582 hasConcept C71924100 @default.
• W1805997582 hasConcept C86803240 @default.
• W1805997582 hasConcept C89423630 @default.
• W1805997582 hasConcept C98274493 @default.
• W1805997582 hasConcept C99454951 @default.
• W1805997582 hasConceptScore W1805997582C126322002 @default.
• W1805997582 hasConceptScore W1805997582C162156334 @default.
• W1805997582 hasConceptScore W1805997582C2776026265 @default.
• W1805997582 hasConceptScore W1805997582C2776186584 @default.
• W1805997582 hasConceptScore W1805997582C2776908094 @default.
• W1805997582 hasConceptScore W1805997582C2777499811 @default.
• W1805997582 hasConceptScore W1805997582C2781348000 @default.
• W1805997582 hasConceptScore W1805997582C2781413609 @default.
• W1805997582 hasConceptScore W1805997582C2908647359 @default.
• W1805997582 hasConceptScore W1805997582C42972112 @default.
• W1805997582 hasConceptScore W1805997582C61716771 @default.
• W1805997582 hasConceptScore W1805997582C71924100 @default.
• W1805997582 hasConceptScore W1805997582C86803240 @default.
• W1805997582 hasConceptScore W1805997582C89423630 @default.
• W1805997582 hasConceptScore W1805997582C98274493 @default.
• W1805997582 hasConceptScore W1805997582C99454951 @default.
• W1805997582 hasIssue "1-2" @default.
• W1805997582 hasLocation W18059975821 @default.
• W1805997582 hasLocation W18059975822 @default.
• W1805997582 hasOpenAccess W1805997582 @default.
• W1805997582 hasPrimaryLocation W18059975821 @default.
• W1805997582 hasRelatedWork W2014030712 @default.
• W1805997582 hasRelatedWork W2028253687 @default.
• W1805997582 hasRelatedWork W2031809258 @default.
• W1805997582 hasRelatedWork W2104905944 @default.
• W1805997582 hasRelatedWork W2241457701 @default.
• W1805997582 hasRelatedWork W2323440822 @default.

• next